Entero Regains Nasdaq Compliance With Grid AI Acquisition
Entero Therapeutics, Inc. ("Entero" or the "Company") (NASDAQ:ENTO) is pleased to announce that, as a result of the acquisition of 100% of Grid AI Corp. ("Grid AI"), it has regained compliance with Nasdaq Listing Rule 5550(b)(1) (the "Equity Rule"). Entero's publicly‑listed platform now sits at the intersection of AI, data centers, power grids, and global infrastructure. The acquisition of Grid AI, now operating as a wholly‑owned subsidiary of...
Read more









